No. of patients with S. marcescens = 43 | |||||||
---|---|---|---|---|---|---|---|
Drug groups | Active substance | No. using antibiotics (%) | No. of tests of antibiotics on antibiogram (%) | Sensitive (%) | Intermediate (%) | Resistant (%) | P value compared to ampicillin |
Penicillins | Ampicillin | 0 | 43 (100) | 0 | 0 | 43 (100) | |
Piperacillin | 0 | 43 (100) | 31 (72.1) | 5 (11.6) | 7 (16.3) | < 0.0001 | |
Penicillin + Beta-lactamase inhibitors | Ampicillin + Sulbactam | 3 (7.0) | 43 (100) | 0 | 0 | 43 (100) | 1.0 |
Piperacillin + Tazobactam | 21 (48.8) | 43 (100) | 38 (88.3) | 1 (2.3) | 4 (9.3) | < 0.0001 | |
Cephalosporins | Cefepime | 2 (4.7) | 39 (90.7) | 39 (100) | 0 | 0 | < 0.0001 |
Cefotaxime | 0 | 43 (100) | 36 (83.7) | 2 (4.7) | 5 (11.6) | < 0.0001 | |
Ceftazidime | 1 (2.3) | 39 (90.7) | 39 (100) | 0 | 0 | < 0.0001 | |
Cefuroxime | 4 (9.3) | 43 (100) | 0 | 0 | 43 (100) | 1.0 | |
Glycylcycline | Tetracycline | 0 | 17 (39.5) | 3 (17.6) | 2 (11.8) | 12 (70.6) | 0.001 |
Tigecycline | 0 | 5 (11.6) | 3 (60.0) | 2 (40.0) | 0 | < 0.0001 | |
Carbapenems | Imipenem | 5 (11.6) | 43 (100) | 42 (97.7) | 0 | 1 (2.3) | < 0.0001 |
Meropenem | 2 (4.7) | 42 (97.7) | 41 (97.6) | 1 (2.4) | 0 | < 0.0001 | |
Gyrase inhibitors | Ciprofloxacin | 4 (9.3) | 42 (97.7) | 37 (88.1) | 2 (4.8) | 3 (7.1) | < 0.0001 |
Levofloxacin | 3 (7.0) | 28 (65.1) | 26 (92.9) | 0 | 2 (7.1) | < 0.0001 | |
Aminoglycoside | Amikacin | 0 | 26 (60.5) | 18 (69.2) | 8 (30.8) | 0 | < 0.0001 |
Gentamicin | 2 (4.7) | 40 (93.0) | 38 (95.0) | 2 (5.0) | 0 | < 0.0001 | |
Tobramycin | 0 | 27 (62.8) | 16 (59.3) | 4 (14.8) | 7 (25.9) | < 0.0001 | |
Trimethoprim + Sulfamethoxazole | Co-trimoxazole | 0 | 42 (97.7) | 39 (92.9) | 0 | 3 (7.1) | < 0.0001 |
Others | Fosfomycin | 0 | 17 (39.5) | 17 (100) | 0 | 0 | < 0.0001 |